INR 883.3
(2.2%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.38 Billion INR | 77.93% |
2022 | 777.55 Million INR | 57.19% |
2021 | 494.66 Million INR | 157.92% |
2020 | 191.79 Million INR | -2.4% |
2019 | 196.49 Million INR | -4.99% |
2018 | 206.81 Million INR | -6.06% |
2017 | 220.16 Million INR | -29.08% |
2016 | 310.44 Million INR | 55.29% |
2015 | 199.91 Million INR | -1.35% |
2014 | 202.66 Million INR | 15.37% |
2013 | 175.66 Million INR | 13.22% |
2012 | 155.15 Million INR | -1.63% |
2011 | 157.72 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -899.76 Million INR | -165.03% |
2023 Q2 | 819.12 Million INR | 0.0% |
2023 FY | 1.38 Billion INR | 77.93% |
2023 Q4 | 1.38 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2022 Q4 | 777.55 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 777.55 Million INR | 57.19% |
2022 Q2 | 715.62 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 FY | 494.66 Million INR | 157.92% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 314.76 Million INR | 0.0% |
2021 Q4 | 494.66 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 191.79 Million INR | -2.4% |
2020 Q4 | 191.79 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 277.86 Million INR | 0.0% |
2019 Q4 | 196.49 Million INR | 0.0% |
2019 FY | 196.49 Million INR | -4.99% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 246.34 Million INR | 0.0% |
2018 FY | 206.81 Million INR | -6.06% |
2018 Q4 | 206.81 Million INR | 0.0% |
2018 Q2 | 254.37 Million INR | 0.0% |
2017 Q2 | 184.13 Million INR | 0.0% |
2017 Q4 | 220.16 Million INR | 0.0% |
2017 FY | 220.16 Million INR | -29.08% |
2016 Q1 | 237.3 Million INR | 0.0% |
2016 FY | 310.44 Million INR | 55.29% |
2016 Q4 | 310.44 Million INR | 27.33% |
2016 Q3 | 243.81 Million INR | 0.0% |
2015 FY | 199.91 Million INR | -1.35% |
2014 FY | 202.66 Million INR | 15.37% |
2013 FY | 175.66 Million INR | 13.22% |
2012 FY | 155.15 Million INR | -1.63% |
2011 FY | 157.72 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Biocon Limited | 307.95 Billion INR | 99.551% |
Blue Jet Healthcare Limited | 2.13 Billion INR | 35.235% |
Concord Biotech Limited | 1.74 Billion INR | 20.516% |
Dishman Carbogen Amcis Limited | 39.53 Billion INR | 96.501% |
Jubilant Ingrevia Limited | 19.94 Billion INR | 93.063% |
Lyka Labs Limited | 884.58 Million INR | -56.403% |
Panacea Biotec Limited | 4.02 Billion INR | 65.586% |
Piramal Pharma Limited | 74 Billion INR | 98.13% |
SMS Lifesciences India Limited | 1.96 Billion INR | 29.729% |
Supriya Lifescience Limited | 1.05 Billion INR | -30.681% |
Syngene International Limited | 18.93 Billion INR | 92.695% |
TAKE Solutions Limited | 969.78 Million INR | -42.663% |